Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -9.98% |
|
-.--% | +29.82% |
27/06 | Hansa Biopharma AB Announces Board Appointments | CI |
31/05 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- HNSA Stock
- HNSBF Stock
- Charts Hansa Biopharma AB